The American pharmaceutical company MSD is halting the supply of vaccines against chicken pox, measles, rubella and mumps to Russia. About it writes “Kommersant” with reference to several market participants.
According to the publication, MSD has sent relevant notices to market participants. The letter was received, for example, by the Perm Center for Immunology and Vaccination.
The information about the suspension of cooperation with MSD was also confirmed in the Nacimbio holding – since 2019, the production of MSD vaccines against chickenpox, rotavirus infection and human papillomavirus has been localized at its Forta site since 2019. The site is now producing seasonal vaccines.
The company itself told Kommersant that it was “making every effort” to supply vital drugs and vaccines, which have no analogues in Russia.
The publication clarifies that the drugs that MSD ceases to supply have analogues in Russia. The varicella vaccine is supplied by GSK, and the measles, rubella and mumps vaccine by Vactrivir is supplied by Microgen.
The press service of Roszdravnadzor said that Russia has “a sufficient number of domestic vaccines” for the prevention of chicken pox, measles, rubella and mumps. According to Alexei Kuznetsov, Assistant Minister of Health of Russia, the termination of the supply of MSD vaccines to the country will not negatively affect the availability of vaccination for Russians.
Since the start of the war, more than a thousand Western companies have already left Russia. At the same time, the country’s authorities promise to replace imported goods with domestic ones. For example, they plan to assemble Muscovites at the Renault plant, and replace Coca-Cola with Komi Cola.